Showing results (151-160 of 333) with videos related to

Sort By:
Pageof 34
Blood Cancer Discovery|December 19, 2022
Genetic Modeling of B-cell State Transitions for Rational Design of Lymphoma TherapiesEtienne Leveille, Shalin Kothari, Markus Müschen
Blood Cancer Discovery|December 1, 2022
Immunosuppressive Extracellular Vesicles in CLLWenqun Zhong, Wei Guo
Blood Cancer Discovery|April 11, 2022
Type I but Not Type II Calreticulin Mutations Activate the IRE1α/XBP1 Pathway of the Unfolded Protein Response to Drive Myeloproliferative NeoplasmsJuan Ibarra, Yassmin A Elbanna, Katarzyna Kurylowicz, et al.
Blood Cancer Discovery|April 17, 2024
Disruption of KLHL6 Fuels Oncogenic Antigen Receptor Signaling in B-Cell LymphomaLeo Meriranta, Selma Sorri, Kanutte Huse, et al.
Blood Cancer Discovery|February 19, 2021
Preneoplastic Alterations Define CLL DNA Methylome and Persist through Disease Progression and TherapyHelene Kretzmer, Anat Biran, Noelia Purroy, et al.
Blood Cancer Discovery|April 28, 2025
Putting AML Differentiation States on the BoneMarrowMapJonas Berger, Livius Penter
Blood Cancer Discovery|May 22, 2025
Mutagenic impact and evolutionary influence of chemo-radiotherapy in hematologic malignanciesBenjamin Diamond, Dhanvantri Chahar, Michael D Jain, et al.
Blood Cancer Discovery|May 21, 2025
Genetic and Phenotypic correlates of clinical outcomes with Venetoclax in Acute Myeloid Leukemia: The GEN-PHEN-VEN studyCurtis A Lachowiez, Mael Heiblig, Gaspar Aspas Requena, et al.
Blood Cancer Discovery|February 11, 2026
Prognostic Model Combining Mutational and Cytogenetic Profiles in Acute Myeloid Leukemia Treated with Venetoclax and Hypomethylating AgentsDimitrios Drekolias, Fatima Tuz Zahra, Caroline Fileni, et al.
Blood Cancer Discovery|February 13, 2026
Clinical scores to predict toxicities and outcomes in patients with multiple myeloma undergoing bispecific T-cell engager therapyJan H Frenking, Christine Riedhammer, Thomas Hielscher, et al.
Pageof 34